Genome-wide association study implicates immune activation of multiple interin genes in inflammatory bowel disease
暂无分享,去创建一个
J. Barrett | M. Tremelling | M. Parkes | C. Lees | E. Nimmo | J. Satsangi | N. Prescott | J. Sanderson | C. Mathew | J. Mansfield | T. Ahmad | L. Jostins | C. Hawkey | C. Edwards | James C. Lee | C. Mowat | W. Newman | L. Moutsianas | A. Hart | C. Lamb | Yang Luo | N. Kennedy | D. Rice | J. Gutiérrez-Achury | S. Ji | G. Heap | P. Henderson | A. Simmons | H. Uhlig | D. Wilson | K. D. Lange | Javier Gutiérrez-Achury | L. Moutsianas
[1] A. Hofman,et al. Hypothesis-free identification of modulators of genetic risk factors , 2015, bioRxiv.
[2] Emmanouil T. Dermitzakis,et al. Fast and efficient QTL mapper for thousands of molecular phenotypes , 2015, bioRxiv.
[3] M. Daly,et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.
[4] Roderic Guigó,et al. Identification of genetic variants associated with alternative splicing using sQTLseekeR , 2014, Nature Communications.
[5] Richard Durbin,et al. Efficient haplotype matching and storage using the positional Burrows–Wheeler transform (PBWT) , 2014, Bioinform..
[6] D. Koller,et al. Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals , 2013, Genome research.
[7] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[8] Jake K. Byrnes,et al. Bayesian refinement of association signals for 14 loci in 3 common diseases , 2012, Nature Genetics.
[9] G. Greenberg,et al. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. , 2012, The New England journal of medicine.
[10] James A. Morris,et al. optiCall: a robust genotype-calling algorithm for rare, low-frequency and common variants , 2012, Bioinform..
[11] Jon Wakefield,et al. Bayes factors for genome‐wide association studies: comparison with P‐values , 2009, Genetic epidemiology.
[12] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[13] P. Rutgeerts,et al. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. , 2007, Gastroenterology.
[14] S. Hanauer,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .